A 52-year-old man with myasthenia gravis is treated with neostigmine, while a 48-year-old woman with atropine poisoning and altered mental status is given physostigmine. Which pharmacokinetic feature best explains why these drugs are chosen for their respective conditions?

Explanation

## Clinical Selection Based on BBB Penetration **Key Point:** The choice between neostigmine and physostigmine is determined by whether CNS penetration is needed. Myasthenia gravis (peripheral neuromuscular junction) requires neostigmine; anticholinergic poisoning with CNS manifestations requires physostigmine. ### Myasthenia Gravis → Neostigmine - Pathology is at the neuromuscular junction (peripheral) - Neostigmine's quaternary ammonium structure prevents BBB crossing - Concentrates effect at the NMJ without unwanted CNS cholinergic effects - Oral formulation available for chronic dosing ### Atropine Poisoning with CNS Symptoms → Physostigmine - Atropine blocks both muscarinic receptors peripherally AND centrally - Central anticholinergic effects: confusion, hallucinations, seizures, agitation - Physostigmine's tertiary amine structure allows BBB penetration - Reverses both peripheral AND central anticholinergic manifestations - IV formulation for rapid onset in acute toxicity ## Comparison Table: When to Use Which | Condition | Drug | Reason | |-----------|------|--------| | Myasthenia gravis (chronic) | Neostigmine | Peripheral NMJ disease; BBB impermeability is advantageous | | Anticholinergic toxicity (CNS symptoms) | Physostigmine | CNS penetration needed to reverse central effects | | Anticholinergic toxicity (peripheral only) | Either | Both work; neostigmine is safer (no CNS cholinergic excess) | | Glaucoma | Neostigmine (eye drops) | Local ocular effect; systemic BBB irrelevant | | Postoperative ileus | Neostigmine | Peripheral GI smooth muscle; no CNS involvement | **High-Yield:** "Quaternary = peripheral; tertiary = central." This mnemonic encodes the structural basis of drug distribution and is tested repeatedly in NEET PG. **Clinical Pearl:** In anticholinergic overdose, if the patient presents with ONLY peripheral signs (dry mouth, urinary retention, tachycardia), neostigmine is adequate and safer. If CNS signs are present (confusion, agitation, seizures), physostigmine is mandatory. **Warning:** Do not give physostigmine to patients with anticholinergic toxicity who have only peripheral signs—the resulting CNS cholinergic excess (bradycardia, bronchospasm, seizures from excessive acetylcholine) can be dangerous. [cite:KD Tripathi 8e Ch 6]